ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

70 hedge funds and large institutions have $229M invested in Albireo Pharma, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 9 closing their positions.

Holders
70
Holders Change
+1
Holders Change %
+1.45%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
28
Reduced
19
Closed
9
Calls
$101K
Puts
$43K
Net Calls
+$58K
Net Calls Change
+$388K

Top Buyers

1
ACH
1
ArrowMark Colorado Holdings
Colorado
$22M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$5.39M
3
EP
3
Eversept Partners
New York
$1.98M
4
BlackRock
4
BlackRock
New York
$18M
5
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$864K

Top Sellers

1
TGHSA
1
TPG Group Holdings (SBS) Advisors
Texas
$12.4M
2
SAM
2
Sectoral Asset Management
Quebec, Canada
$0
3
Man Group
3
Man Group
United Kingdom
$2.39M
4
CC
4
Chicago Capital
Illinois
$4.46M
5
HA
5
Heartland Advisors
Wisconsin
$2.54M
Name Market Value Shares Shares
Change 		Shares
Change %
PHK
76
Point72 Hong Kong
Hong Kong
– – -56 Closed
PMFA
77
Plante Moran Financial Advisors
Michigan
– – -49 Closed
Fifth Third Bancorp
78
Fifth Third Bancorp
Ohio
– – -7 Closed
CFGS
79
Concourse Financial Group Securities
Alabama
– – – –
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
– – – –
SWM
81
Sugarloaf Wealth Management
Georgia
$0 11 +11 New
1 2 3
4